Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) clinical trial (NCT02588625). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I be aware of with BMS-986020?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) clinical trial (NCT02588625). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) clinical trial (NCT02588625). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) clinical trial (NCT02588625). Contact the study team or your healthcare provider for specific answers.

Question 5

Will I receive the active treatment or the placebo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) clinical trial (NCT02588625). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Double-Blinded Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986020 Versus Placebo in Diffuse Cutaneous Systemic Sclerosis (dcSSc) clinical trial (NCT02588625). Contact the study team or your healthcare provider for specific answers.

What this study is about